Literature DB >> 7638593

Women in clinical trials: an FDA perspective.

L A Sherman1, R Temple, R B Merkatz.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  1995        PMID： 7638593     DOI： 10.1126/science.7638593

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  8 in total

1.  Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study.

Authors:  Kathleen Squires; Cissy Kityo; Sally Hodder; Margaret Johnson; Evgeny Voronin; Debbie Hagins; Anchalee Avihingsanon; Ellen Koenig; Shuping Jiang; Kirsten White; Andrew Cheng; Javier Szwarcberg; Huyen Cao
Journal:  Lancet HIV       Date:  2016-05-27       Impact factor: 12.767

2.  Week 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128).

Authors:  Rima Kulkarni; Sally L Hodder; Huyen Cao; Silvia Chang; Michael D Miller; Kirsten L White
Journal:  HIV Clin Trials       Date:  2017-07

3.  Women's health and clinical trials.

Authors:  Londa Schiebinger
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 4.  Exploring the Food and Drug Administration's review and approval of Entresto (sacubitril/valsartan).

Authors:  Ashley L Eadie; Keith R Brunt; Matthew Herder
Journal:  Pharmacol Res Perspect       Date:  2021-05

5.  Host sexual dimorphism and parasite adaptation.

Authors:  David Duneau; Dieter Ebert
Journal:  PLoS Biol       Date:  2012-02-28       Impact factor: 8.029

6.  Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials.

Authors:  Melba F Gomes; Vânia de la Fuente-Núñez; Abha Saxena; Annette C Kuesel
Journal:  Reprod Health       Date:  2017-12-14       Impact factor: 3.223

7.  Insulin sensitivity in critically ill patients: are women more insulin resistant?

Authors:  Vincent Uyttendaele; J Geoffrey Chase; Jennifer L Knopp; Rebecca Gottlieb; Geoffrey M Shaw; Thomas Desaive
Journal:  Ann Intensive Care       Date:  2021-01-21       Impact factor: 6.925

8.  The Toll pathway underlies host sexual dimorphism in resistance to both Gram-negative and Gram-positive bacteria in mated Drosophila.

Authors:  David F Duneau; Hannah C Kondolf; Joo Hyun Im; Gerardo A Ortiz; Christopher Chow; Michael A Fox; Ana T Eugénio; J Revah; Nicolas Buchon; Brian P Lazzaro
Journal:  BMC Biol       Date:  2017-12-21       Impact factor: 7.431
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.